Hazim Alkousheh

Dr. Hazim Alkousheh

Faculty of Medicine, The Hashemite University, Zarqa, Jordan
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
HAHazim Alkousheh
Hazim Alkousheh
YAYara Alkousheh
Yara Alkousheh
RQRana Qawaqzeh
Rana Qawaqzeh
LJLayan Al Juneidi
Layan Al Juneidi
LALina Al-Zerikat
Lina Al-Zerikat
MAMotasem Al-Latayfeh
Motasem Al-Latayfeh
Objective Increased screen time has resulted in widespread computer vision syndrome (CVS) in the digital era. Medical students, who rely heavily on digital screens, are particularly at risk. Our study aims to evaluate the prevalence of CVS among Jordanian medical students, which is a gap in existing knowledge. Design Cross-sectional study Setting National multicentre study conducted across six universities in Jordan. Participants Medical students from first to sixth year. Primary and secondary outcome measures Primary outcome: Prevalence of CVS among medical students in Jordan. Secondary outcomes: Identification of risk factors associated with CVS, assessment of the correlation between screen time and the severity of CVS symptoms. Results The prevalence of CVS among medical students was 56.3%. Among the 833 participants, 543 were females (65.2%) and 290 were males (34.8%). The CVS group reported a median of five symptoms, whereas two symptoms were reported in the non-CVS group (p<0.001). Compared with males, females reported significantly more symptoms (p<0.001). Dry eyes (26.3%) and headaches (25.9%) were the most reported symptoms. Continuous screen use was associated with CVS group status (p=0.008). Moderate positive correlations were found between the number of symptoms and the frequency of monthly symptom attacks and between the duration and frequency of symptom attacks (p<0.001). Conclusion Our study found a 56.3% prevalence of CVS among Jordanian medical students, with over 80% having ocular and extraocular symptoms. Symptoms, attack duration and frequency were higher, especially in females, highlighting the need for preventive measures and increased awareness about prolonged screen use.

19 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AEAmr Elrosasy
Amr Elrosasy
MZMohamed Abo Zeid
Mohamed Abo Zeid
RSRaghad Samha
Raghad Samha
HAHazim Alkousheh
Hazim Alkousheh
SCShirin Cadri
Shirin Cadri
EAEsraa M. AlEdani
Esraa M. AlEdani
Background: Hyperhidrosis (HH), characterized by excessive sweating, poses a significant challenge to patients’ quality of life. This meta-analysis evaluates the safety and efficacy of topical glycopyrronium bromide (GBP) in treating primary hyperhidrosis, a chronic condition affecting various body regions. Despite its prevalence, primary axillary hyperhidrosis is often undertreated due to a lack of awareness and social stigma. Methods: Following PRISMA guidelines, we conducted a systematic review and meta-analysis of randomized controlled trials comparing GBP to a placebo in primary hyperhidrosis patients. Eligibility criteria included outcomes related to perspiration suppression and symptom improvement. Results: Four RCTs involving 1401 patients were included. GBP significantly increased Hyperhidrosis Disease Severity Scale (HDSS) responders (RR = 2.33, 95% CI [1.99 to 2.74], p < 0.00001) and Axillary Sweating Daily Diary (ASDD/ASDD-C) responders (MD = 3.07, 95% CI [2.32 to 4.06], p < 0.002) without significantly causing adverse events. Dermatology life quality index was also significantly improved in the GBP group (MD = -2.32, 95% CI [-3.09, -1.55], P < 0.00001). Conclusion: GBP demonstrated effectiveness in reducing sweat production while improving HDSS and DLQI scores. Adverse events included dry mouth and anticholinergic effects. Dry eye and local skin reactions were not significant, which makes GBP promising in managing primary hyperhidrosis, offering improvements in symptoms and quality of life. While adverse events should be considered, further research with larger sample sizes and long-term follow-up is warranted for comprehensive clinical integration.

29 April 2025 in Updates in Surgery
Verified
Journal Article
Open access
PDF file
MHMahmoud Diaa Hindawi
Mahmoud Diaa Hindawi
RQRuaa Mustafa Qafesha
Ruaa Mustafa Qafesha
AAAhmed Hamdy G. Ali
Ahmed Hamdy G. Ali
HAHazim Alkousheh
Hazim Alkousheh
HEHatem Eldeeb
Hatem Eldeeb
AEAmr Elrosasy
Amr Elrosasy
Midline laparotomy incision is mostly used in emergent surgery, especially in hemodynamic instability patients. We aim to compare the Modified Smead–Jones (MSJ) and Smead–Jones (SJ) sutures against conventional continuous suture in midline laparotomy closure. PubMed, Scopus, Web of Science, and Ovoid were searched. We utilized Revman 5.4.1 for statistical analysis. Five studies involving 403 patients were included. Compared to continuous sutures, MSJ showed a significant reduction in wound dehiscence, wound infection, and hospital stay (RR = 0.29, 95% CI [0.14–0.59], p = 0.0006), (RR = 0.41, 95% CI [0.26–0.65], p = 0.0002), and (MD = – 4.50, 95% CI [– 5.43 to – 3.57], p = 0.00001). Conversely, the SJ subgroup showed no statistically significant difference in wound dehiscence, wound infection, and hospital stay. Also, both techniques, MSJ and SJ, showed no significant difference in incisional hernia risk (RR = 0.17, 95% CI [0.02–1.33], p = 0.09) and (RR = 5.16, 95% CI [0. 26–103.27], p = 0.28), respectively. MSJ follows the same far-near-near-far pattern as SJ but is applied continuously rather than interrupted. The MSJ suture technique might be promising in reducing wound dehiscence, infection, and hospital stay compared to conventional continuous closure. However, future large-scale RCTs with standardized methodologies and extended follow-up are essential to determine whether MSJ should be established as the preferred technique for midline laparotomy closure.

7 March 2025 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
MZMohamed Abo Zeid
Mohamed Abo Zeid
AEAmr Elrosasy
Amr Elrosasy
HAHazim Alkousheh
Hazim Alkousheh
RMRashad G. Mohamed
Rashad G. Mohamed
EAEsraa M. AlEdani
Esraa M. AlEdani
HYHanaa Sayed Suliman Yousef
Hanaa Sayed Suliman Yousef


21 November 2025 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
MSMohamed F. Srour
Mohamed F. Srour
ASAhmed H. Shoaib
Ahmed H. Shoaib
HAHazim Alkousheh
Hazim Alkousheh
KEKarim K. Eladawy
Karim K. Eladawy
MAMohamed Alayat
Mohamed Alayat
MAMohammad A. Abd-Errazik
Mohammad A. Abd-Errazik
The integration of robotic-assisted surgery (RAS) in low- and middle-income countries (LMIC) is hindered by significant perception gaps among key stakeholders. This study evaluated the awareness, knowledge, and perceptions of RAS in Egypt to identify barriers to its adoption. A national, multi-center, cross-sectional study was conducted across ten Egyptian university hospitals (Nov 2024–Apr 2025). Validated questionnaires were administered to three cohorts: general surgical patients ( n = 539), surgeons ( n = 486), and RAS-experienced patients ( n = 32). Multivariable logistic regression identified predictors of patient preference and surgeon support for RAS. A stark perception gap was observed. Surgeon awareness was high (90.7%), but knowledge was limited; only 56.8% knew RAS was available in Egypt. Despite this, 80.0% supported national implementation, which was independently predicted by awareness of local availability (aOR 6.35, 95% CI 3.25–12.42) and correct technical understanding (aOR 2.49, 1.48–4.18). Conversely, patient awareness was low (30.4%), with high prevalence of fears regarding malfunction (63.3%). Only 20.0% preferred RAS. Patient preference was associated with the absence of fears (aOR 0.08, 0.04–0.16) and belief in improved outcomes (aOR 4.08, 2.10–7.94). RAS-experienced patients, informed primarily by surgeons (90.6%), reported high satisfaction (84.4% “Very Good”/“Excellent”) and were strong advocates (90.6% would recommend it). RAS adoption in Egypt appears to be influenced mainly by modifiable perceptual barriers rather than demographics. Surgeons are generally supportive but under-informed, while patient hesitancy seems driven by fear that can lessen after direct exposure and education. National strategies should prioritize targeted education and the use of positive patient experiences to help address these gaps.